If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> <br /> INSIGHTS<br /> 2012<br /> ADVANCING THE SCIENCE OF PHARMACY CARE<br /> connected<br /> <br /> 2012<br /> Tremendous shifts are underway in health care. We’re midway between passage of the<br /> Affordable Care Act (ACA) and the implementation of its major provisions, but the market<br /> is moving now, and not only to accommodate reform. Regardless of what happens on the<br /> national front, all of us in health care recognize the need for new solutions.<br /> Health care stakeholders are evaluating options, next steps, and new models. In many cases,<br /> those next steps involve forming new alliances. Plans and providers are joining together to<br /> explore new ways to expand capabilities and improve quality while reducing cost.<br /> Collaboration is at the base of many of these new solutions, whether they involve a new<br /> care delivery model like an ACO or determining how to build a formulary that will meet<br /> member needs and manage health con<a title="CVS Caremark Insights 2012 page 1" href="http://viewer.zmags.com/publication/dde38afc?page=1"> </a> <a title="CVS Caremark Insights 2012 page 2" href="http://viewer.zmags.com/publication/dde38afc?page=2"> INSIGHTS 2012 ADVANCING THE SCIENCE OF PHARMACY</a> <a title="CVS Caremark Insights 2012 page 3" href="http://viewer.zmags.com/publication/dde38afc?page=3"> </a> <a title="CVS Caremark Insights 2012 page 4" href="http://viewer.zmags.com/publication/dde38afc?page=4"> 2012 Tremendous shifts are underway in health car</a> <a title="CVS Caremark Insights 2012 page 5" href="http://viewer.zmags.com/publication/dde38afc?page=5"> INSIGHTS Editorial Direction Per Lofberg, MS Tro</a> <a title="CVS Caremark Insights 2012 page 6" href="http://viewer.zmags.com/publication/dde38afc?page=6"> Table of Contents One Overwhelming Concern—Cost </a> <a title="CVS Caremark Insights 2012 page 7" href="http://viewer.zmags.com/publication/dde38afc?page=7"> One cost Overwhelming Concern INSIGHTS U.S. hea</a> <a title="CVS Caremark Insights 2012 page 8" href="http://viewer.zmags.com/publication/dde38afc?page=8"> Resurgence of utilization is inevitable and neces</a> <a title="CVS Caremark Insights 2012 page 9" href="http://viewer.zmags.com/publication/dde38afc?page=9"> 2.5 M More young adults now have coverage 2.65 M</a> <a title="CVS Caremark Insights 2012 page 10" href="http://viewer.zmags.com/publication/dde38afc?page=10"> i m p r o v i n g a c c e s s The Affordable C</a> <a title="CVS Caremark Insights 2012 page 11" href="http://viewer.zmags.com/publication/dde38afc?page=11"> help them buy insurance. Many of those seeking in</a> <a title="CVS Caremark Insights 2012 page 12" href="http://viewer.zmags.com/publication/dde38afc?page=12"> employers are likely to move from a defined benef</a> <a title="CVS Caremark Insights 2012 page 13" href="http://viewer.zmags.com/publication/dde38afc?page=13"> INSIGHTS  </a> <a title="CVS Caremark Insights 2012 page 14" href="http://viewer.zmags.com/publication/dde38afc?page=14"> i n c r e a s i n g q u a l i t y Health Care R</a> <a title="CVS Caremark Insights 2012 page 15" href="http://viewer.zmags.com/publication/dde38afc?page=15"> (continued from page 10) The PCMH model and conce</a> <a title="CVS Caremark Insights 2012 page 16" href="http://viewer.zmags.com/publication/dde38afc?page=16"> on the Exchanges to tracking performance data for</a> <a title="CVS Caremark Insights 2012 page 17" href="http://viewer.zmags.com/publication/dde38afc?page=17"> INSIGHTS trend 2011 Prescription Drug</a> <a title="CVS Caremark Insights 2012 page 18" href="http://viewer.zmags.com/publication/dde38afc?page=18"> Managing Pharmacy Trend: New Challenges Price wa</a> <a title="CVS Caremark Insights 2012 page 19" href="http://viewer.zmags.com/publication/dde38afc?page=19"> $5.8B (continued from </a> <a title="CVS Caremark Insights 2012 page 20" href="http://viewer.zmags.com/publication/dde38afc?page=20"> 26 are not heavy users of prescription therapy •</a> <a title="CVS Caremark Insights 2012 page 21" href="http://viewer.zmags.com/publication/dde38afc?page=21"> 34% between generics and preferred brands </a> <a title="CVS Caremark Insights 2012 page 22" href="http://viewer.zmags.com/publication/dde38afc?page=22"> Figure 4 54.4% OF EMPLOYER CLIENTS HAVE A GROSS </a> <a title="CVS Caremark Insights 2012 page 23" href="http://viewer.zmags.com/publication/dde38afc?page=23"> GDR Forecast 2012: Twenty-five percent of plan</a> <a title="CVS Caremark Insights 2012 page 24" href="http://viewer.zmags.com/publication/dde38afc?page=24"> CVS Caremark Drug Trend Forecasts UTILIZATION RA</a> <a title="CVS Caremark Insights 2012 page 25" href="http://viewer.zmags.com/publication/dde38afc?page=25"> INSIGHTS Specialty Drugs Will Soon </a> <a title="CVS Caremark Insights 2012 page 26" href="http://viewer.zmags.com/publication/dde38afc?page=26"> Three specialty drugs were among the 2010 top 10 </a> <a title="CVS Caremark Insights 2012 page 27" href="http://viewer.zmags.com/publication/dde38afc?page=27"> 63% HEALTH PLAN SURVEY of </a> <a title="CVS Caremark Insights 2012 page 28" href="http://viewer.zmags.com/publication/dde38afc?page=28"> 2011 APPROVALS AND 2012 POTENTIAL NEW PRODUCT APP</a> <a title="CVS Caremark Insights 2012 page 29" href="http://viewer.zmags.com/publication/dde38afc?page=29"> Rapid advances in technology and better understan</a> <a title="CVS Caremark Insights 2012 page 30" href="http://viewer.zmags.com/publication/dde38afc?page=30"> Restricted annual limits will continue to be impo</a> <a title="CVS Caremark Insights 2012 page 31" href="http://viewer.zmags.com/publication/dde38afc?page=31"> 50% orthopedic surgeries, such as hip or </a> <a title="CVS Caremark Insights 2012 page 32" href="http://viewer.zmags.com/publication/dde38afc?page=32"> New, more effective regimens are reviving interes</a> <a title="CVS Caremark Insights 2012 page 33" href="http://viewer.zmags.com/publication/dde38afc?page=33"> • Among privately-insured individuals under a</a> <a title="CVS Caremark Insights 2012 page 34" href="http://viewer.zmags.com/publication/dde38afc?page=34"> Health plans value the extensive patient manageme</a> <a title="CVS Caremark Insights 2012 page 35" href="http://viewer.zmags.com/publication/dde38afc?page=35"> Managing New Cost Dynamics Future specialty provi</a> <a title="CVS Caremark Insights 2012 page 36" href="http://viewer.zmags.com/publication/dde38afc?page=36"> coordinated specialty pharmacy care: hemophilia </a> <a title="CVS Caremark Insights 2012 page 37" href="http://viewer.zmags.com/publication/dde38afc?page=37"> (continued on page 32) Rigorous clinical, safety </a> <a title="CVS Caremark Insights 2012 page 38" href="http://viewer.zmags.com/publication/dde38afc?page=38"> Reinventing Pharmacy The health care landscape </a> <a title="CVS Caremark Insights 2012 page 39" href="http://viewer.zmags.com/publication/dde38afc?page=39"> INSIGHTS helping people on their path to better </a> <a title="CVS Caremark Insights 2012 page 40" href="http://viewer.zmags.com/publication/dde38afc?page=40"> CVS Caremark: reinventing pharmacy Being connec</a> <a title="CVS Caremark Insights 2012 page 41" href="http://viewer.zmags.com/publication/dde38afc?page=41"> INSIGHTS advancing the science of pharmacy care </a> <a title="CVS Caremark Insights 2012 page 42" href="http://viewer.zmags.com/publication/dde38afc?page=42"> (continued from page 36) for all CVS pharmacy pat</a> <a title="CVS Caremark Insights 2012 page 43" href="http://viewer.zmags.com/publication/dde38afc?page=43"> 7days/wk INSIGHTS Projected shortage of</a> <a title="CVS Caremark Insights 2012 page 44" href="http://viewer.zmags.com/publication/dde38afc?page=44"> by Column Five Infographic PBM 70 Million Pharm</a> <a title="CVS Caremark Insights 2012 page 45" href="http://viewer.zmags.com/publication/dde38afc?page=45"> 20% of Medicare patients are readmitted to the </a> <a title="CVS Caremark Insights 2012 page 46" href="http://viewer.zmags.com/publication/dde38afc?page=46"> Figure 2 PHARMACY-RELATED QUALITY MEASURES Mea</a> <a title="CVS Caremark Insights 2012 page 47" href="http://viewer.zmags.com/publication/dde38afc?page=47"> References One Overwhelming Concern—Cost INSIGH</a> <a title="CVS Caremark Insights 2012 page 48" href="http://viewer.zmags.com/publication/dde38afc?page=48"> 24. International Journal of MS Care, “Comorbidit</a> <a title="CVS Caremark Insights 2012 page 49" href="http://viewer.zmags.com/publication/dde38afc?page=49"> Figures 4: 54.4% of Employer Clients Have a Tren</a> <a title="CVS Caremark Insights 2012 page 50" href="http://viewer.zmags.com/publication/dde38afc?page=50"> </a> <a title="CVS Caremark Insights 2012 page 51" href="http://viewer.zmags.com/publication/dde38afc?page=51"> Caremark.com ©2012 Caremark. All rights reserved</a>